# FDA OTHER_CORRESPONDENCE - Unknown Company - February 14, 2019

Source: https://www.keypedia.com/records/other_correspondence/unknown-company/fe3cbfae-2a82-40c7-bdc9-b0fdc02052b6

> FDA OTHER_CORRESPONDENCE for Unknown Company on February 14, 2019. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: OTHER_CORRESPONDENCE
- Inspection Date: 2019-02-14
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations I

## Related Documents

- [RESUME - Unknown Date](https://www.keypedia.com/records/resume/unknown-company/f071af8e-ce6c-4c87-947b-39d97b8c2137)
- [RESUME - Unknown Date](https://www.keypedia.com/records/resume/unknown-company/2e526b9d-c43a-4d0b-84be-03a886b460ba)
- [RESUME - Unknown Date](https://www.keypedia.com/records/resume/unknown-company/44d432e6-92fd-498e-9e83-ec26582dd538)
- [RESUME - Unknown Date](https://www.keypedia.com/records/resume/unknown-company/2a5f870a-1893-4ebd-a88d-fa59c4d7559c)
- [483_RESPONSE - 2016-01-29](https://www.keypedia.com/records/483_response/unknown-company/9c3d9cb6-5c40-4b6e-8583-a79cdb64f346)

## Related Officers

- [Acting Chief Scientist](https://www.keypedia.com/people/david-g/af849da1-665f-41f4-b7d9-f48e9845d0c7)
- [John Doe](https://www.keypedia.com/people/john-doe/676f4473-3480-4cc0-be19-1e4afc54232a)
- [Nicholas R. Kirkpatrick](https://www.keypedia.com/people/nicholas-r-kirkpatrick/97bc668b-11f9-43c4-8e5b-114cea0c2f26)
- [Kenneth E. Crawford III](https://www.keypedia.com/people/kenneth-e-crawford-iii/55b336d8-7094-49d3-8ae0-f8edfe9423c0)
- [Program Analyst](https://www.keypedia.com/people/jazmine-n-still/92bc804f-1f4e-46f6-8802-6a65b50f91ae)

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-i/6ded4818-ee3a-46a1-84c1-36de58502b02